Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Lubiprostone
Takeda
Diabetes Mellitus, Type 1
1 trial -
Luo-Fu-Shan Plaster
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Arthritis, Rheumatoid
1 trial -
Luspatercept
The First People's Hospital of Lianyungang
Transfusion-dependent Non-severe Aplastic Anemia
1 trial -
MRI scan
United Therapeutics Europe Ltd
Preterm Birth Complication
1 trial -
MV-PRS Sub-study
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Magnesium Citrate
Taiwan Liposome Company
Cognitive Function
1 trial -
Magnesium Sulfate
Hospital Authority, Hong Kong
Myoma
1 trial -
Mail-in Urine Test for EDCs
Marker Therapeutics
Endocrine Disrupting Chemicals
1 trial -
Manuka honey MGO 1000
United Therapeutics Europe Ltd
Post Surgical Pain
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial -
Meat Biscuit
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Medical Management
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Medical Treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Artery Stenting
1 trial -
Medical Treatment
The First People's Hospital of Lianyungang
Basilar Artery Occlusion
1 trial -
Medical treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Decompensated Cirrhosis
1 trial -
Medical treatment alone
Hospital Authority, Hong Kong
Intracranial Arteriosclerosis
1 trial -
Medium-quantity lipid-based nutrient supplement (MQ-LNS)
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Megestrol acetate
ACTUATE THERAPEUTICS, INC.
HIV Infections
1 trial -
Melatonin supplement intervention
United Therapeutics Europe Ltd
Physical Exercise
1 trial -
Metformin hydrochloride sustained release tablets
The First People's Hospital of Lianyungang
Osteoarthritis
1 trial -
Methotrexate
The First People's Hospital of Lianyungang
Knee Osteoarthritis
1 trial -
Methotrexate
Chinese University of Hong Kong
Rheumatoid Arthritis
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources